Parexel to be acquired in $8.5B private-equity deal
July 02, 2021 at 13:09 PM EDT
Parexel, the clinical research giant co-headquartered in Newton, Mass., and Durham, N.C., is being snapped up in a private-equity deal worth $8.5 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|